Pharmacology & ToxicologybioRxivPreprint
AT1R-Selective Negative Allosteric Modulator Targeting the Epitope for Pathogenic Autoantibody Activation
Khuraijam Dhanachandra Singh, Triveni R. Pardhi, Terri J. Harford…·Sadashiva S. Karnik
This paper develops TP1, an AT1R-selective negative allosteric modulator that blocks autoantibody binding and preserves orthosteric functions, showing therapeutic potential for autoimmune conditions.
DOI 10.64898/2026.10.12.758523